Biotech · Private company
NeuroRx, Inc.
Track this companyFree. Adds NeuroRx, Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials71 recruiting or active
Pipeline programs10From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline10
- Ketamine HydrochloridePhase 3 · Bipolar DepressionClinicalTrials.gov · fetched Nov 12, 2026
- Lurasidone HClPhase 3 · Bipolar DepressionClinicalTrials.gov · fetched Nov 12, 2026
- Neuronavigated robotic-enabled TMSPhase 3 · Treatment Resistant DepressionClinicalTrials.gov · fetched Nov 12, 2026
- NRX-101Phase 3 · Treatment Resistant DepressionClinicalTrials.gov · fetched Nov 12, 2026
- NRX-101Phase 3 · Bipolar DepressionClinicalTrials.gov · fetched Nov 12, 2026
- Sham TMSPhase 3 · Treatment Resistant DepressionClinicalTrials.gov · fetched Nov 12, 2026
- Ketamine Intravenous InfusionPhase 2 · Bipolar DepressionClinicalTrials.gov · fetched Nov 12, 2026
- Lurasidone Oral CapsulePhase 2 · Bipolar DepressionClinicalTrials.gov · fetched Nov 12, 2026
- NRX-101 Oral CapsulePhase 2 · Bipolar DepressionClinicalTrials.gov · fetched Nov 12, 2026
- Transcranial Magnetic Stimulation ShamTreatment-Resistant DepressionClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials7
- A Randomized, Double-Blind Controlled Comparison of NRX-101 vs. Placebo for Adults Being Treated With Robotic Transcranial Magnetic Stimulation for Treatment Resistant Depression: The SPARC-TMS TrialPHASE2_PHASE3 · RECRUITING · started Dec 1, 2026ClinicalTrials.gov NCT07227103 · fetched Nov 12, 2026
- NRX-101 for Bipolar Depression With Subacute Suicidal IdeationPHASE2_PHASE3 · COMPLETED · started May 12, 2022ClinicalTrials.gov NCT03395392 · fetched Nov 12, 2026
- NRX-101 for Maintenance of Remission From Severe Bipolar Depression in Patients With Suicidal IdeationPHASE3 · UNKNOWN · started Dec 1, 2019ClinicalTrials.gov NCT03396068 · fetched Nov 12, 2026
- NRX100 vs. Placebo for Rapid Stabilization of Acute Suicidal Ideation and Behavior in Bipolar DepressionPHASE3 · UNKNOWN · started Jun 25, 2019ClinicalTrials.gov NCT03396601 · fetched Nov 12, 2026
- NRX101 Glx Biomarker Validation StudyPHASE2_PHASE3 · COMPLETED · started Nov 1, 2018ClinicalTrials.gov NCT03402152 · fetched Nov 12, 2026
- Sequential Therapy for the Treatment of Severe Bipolar Depression.PHASE2 · COMPLETED · started Jan 15, 2018ClinicalTrials.gov NCT02974010 · fetched Nov 12, 2026
- NRX-101 Expanded AccessAVAILABLEClinicalTrials.gov NCT05779267 · fetched Nov 12, 2026